Rubicon acquires Canadian firm

摘要

Rubicon Research, a specialty pharmaceutical company, has acquired Impopharma Canada, with operations in Ontario, as part of its ongoing effort to establish a global pharmaceutical development network. Over the next several months, Rubicon plans to establish development plans for a mix of both internal and external development projects.